Clinical Trial Update: Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

View source ↗

Summary

The document reports a completed clinical trial evaluating lenalidomide (Revlimid) for relapsed or refractory adult T-cell leukemia/lymphoma, with results surve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Lymphoma | Status: COMPLETED